Beth C Seidenberg Progyny, Inc. (PGNY) insider trading activity

Beth C Seidenberg is Director of Progyny, Inc.. Currently has a direct ownership of 43,416 shares of PGNY, which is worth approximately $708,983. The most recent transaction as insider was on May 23, 2024, when has been sold 7,206 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.4K

0% 3M change

19.9% 12M change

Total Value Held $708,983

BETH C SEIDENBERG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2024	BUY Grant, award, or other acquisition	-	7,206 Added 14.23%	43,416 Common Stock
Jun 23 2023	BUY Other acquisition or disposition	-	10,284 Added 22.12%	36,210 Common Stock
Jun 09 2023	BUY Other acquisition or disposition	-	6,656 Added 20.43%	25,926 Common Stock
May 24 2023	BUY Grant, award, or other acquisition	-	5,116 Added 20.98%	19,270 Common Stock
Oct 24 2022	BUY Grant, award, or other acquisition	-	4,060 Added 22.29%	14,154 Common Stock
Mar 03 2022	SELL Bona fide gift	-	22,999 Reduced 69.5%	10,094 Common Stock
Dec 22 2021	BUY Other acquisition or disposition	-	15,250 Added 31.55%	33,093 Common Stock
Nov 17 2021	BUY Other acquisition or disposition	-	7,749 Added 30.28%	17,843 Common Stock
Oct 24 2021	BUY Grant, award, or other acquisition	-	3,094 Added 23.46%	10,094 Common Stock
Sep 16 2021	SELL Bona fide gift	-	32,802 Reduced 82.41%	7,000 Common Stock
Jul 19 2021	BUY Other acquisition or disposition	-	20,994 Added 34.53%	39,802 Common Stock
Jun 21 2021	BUY Other acquisition or disposition	-	11,808 Added 38.57%	18,808 Common Stock
May 27 2021	SELL Bona fide gift	-	84,964 Reduced 92.39%	7,000 Common Stock
Mar 30 2021	BUY Other acquisition or disposition	-	49,877 Added 35.16%	91,964 Common Stock
Jan 22 2021	BUY Other acquisition or disposition	-	13,158 Added 23.82%	42,087 Common Stock
Jan 11 2021	SELL Bona fide gift	-	87,141 Reduced 75.08%	28,929 Common Stock
Jan 07 2021	BUY Other acquisition or disposition	-	13,157 Added 10.18%	116,070 Common Stock
Dec 30 2020	BUY Other acquisition or disposition	-	8,772 Added 7.85%	102,913 Common Stock
Nov 30 2020	BUY Other acquisition or disposition	-	24,238 Added 20.47%	94,141 Common Stock
Nov 13 2020	BUY Other acquisition or disposition	-	35,798 Added 33.87%	69,903 Common Stock
Oct 24 2020	BUY Grant, award, or other acquisition	-	7,000 Added 17.03%	34,105 Common Stock

Also insider at

VERA

Vera Therapeutics, Inc. Healthcare

ATRA

Atara Biotherapeutics, Inc. Healthcare

SLRN

ACELYRIN, Inc.

Director

SGMT

Sagimet Biosciences Inc.

Director

KYTX

Kyverna Therapeutics, Inc.

BCS